Digital Pharmacy - Dashboard Peneliti

1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA DB06976

small molecule

Deskripsi belum tersedia.

Target Protein:

Cyclin-dependent kinase 2

Waktu Paruh-

Vol. Distribusi-

Klirens-

Genetik -

12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one DB08703

small molecule

Deskripsi belum tersedia.

Target Protein:

Mitogen-activated protein kinase kinase kinase 9

Waktu Paruh-

Vol. Distribusi-

Klirens-

Genetik -

Esmirtazapine DB06678

small molecule | CAS: 61337-87-9

Esmirtazapine, known by the standardized identifier SCH 900265, was under development by Organon to treat insomnia and vasomotor symptoms associated with menopause. Esmirtazapine is the (S)-(+)-enantiomer of mirtazapine and possesses similar overall pharmacol…

Kategori:

Adrenergic AgentsAdrenergic alpha-2 Receptor AntagonistsAdrenergic alpha-Antagonists +21

Target Protein:

Histamine H1 receptor5-hydroxytryptamine receptor 2Alpha-2 adrenergic receptors

Waktu Paruh10 hours

Vol. Distribusi-

Klirens-

Genetik -

IMIDAZO[2,1-A]ISOQUINOLINE-2-CARBOHYDRAZIDE DB08758

small molecule

Deskripsi belum tersedia.

Target Protein:

Methionine aminopeptidase

Waktu Paruh-

Vol. Distribusi-

Klirens-

Genetik -

Mirtazapine Approved DB00370

small molecule | CAS: 85650-52-8

Mirtazapine is a tetracyclic _piperazino-azepine_ antidepressant agent that was initially approved for the treatment of major depressive disorder (MDD) in the Netherlands in 1994.[A177946] This drug was first manufactured by Organon Inc., and received FDA app…

Kategori:

Adrenergic AgentsAdrenergic alpha-2 Receptor AntagonistsAdrenergic alpha-Antagonists +38

Target Protein:

5-hydroxytryptamine receptor 2A5HT3 serotonin receptorAlpha-2A adrenergic receptor +4

Waktu Paruh20-40 hours [FDA la…

Vol. DistribusiThe volume of distr…

KlirensTotal body clearanc…

Genetik -

Sanfetrinem cilexetil DB19135

small molecule | CAS: 141646-08-4

Sanfetrinem cilexetil is under investigation in clinical trial NCT05388448 (EBA, Safety and Tolerability of Sanfetrinem Cilexetil).

Kategori:

Amides

Waktu Paruh-

Vol. Distribusi-

Klirens-

Genetik -

Hasil Filter

Tipe Molekul

Distribusi Wujud Zat

Status Regulasi

Hasil Pencarian (6)